Latest filing published 01 Oct 2026 for Kymera Therapeutics, Inc., €3.0M.
This profile gathers the share dealings of Mainolfi Nello in Kymera Therapeutics, Inc. We count 3 filings; the first trade dates from 1 July 2026 and the latest from 1 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 1 October 2026 with a transaction (€3.0M) in Kymera Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations